Review Article
Advances in Hybrid Polymer-Based Materials for Sustained Drug Release
Table 2
Main published works regarding biohybrid systems for sustained drug delivery, listed in terms of kind, activity, and encapsulation efficiency (EE%).
| Biohybrid system | Therapeutic molecule | EE% | Ref. |
| NE-alginate/chitosan | Capsaicin | 68.0% | [44] | Emulgel-jojoba oil/HPMC | Clotrimazole | — | [46] | Emulgel-xanthan gum | Acyclovir and ketoconazole | — | [47] | Emulgel-lecithin soy | Ketoprofen | — | [113] | Nanogel-agar | Sodium diclofenac | — | [48] | Emulgel-CMC | Sodium diclofenac | — | [114] | Emulgel-gelatin | Metronidazole | — | [45] | Poly(SMA)-neocarzinostatin | Neocarzinostatin | — | [115] | PEG-DNA | DNA | — | [52] | PEG-streptavidin | Streptavidin | — | [116] | PEG-L-asparaginase | L-Asparaginase | — | [53] | PEG-streptavidin | Streptavidin | — | [117] | PDMA-BSA | DNA | — | [57] | PMMA-BSA | Camptothecin | 11.0% | [56] | ELP-FKBP | Rapamycin | — | [58] | Liposome-chitosan | Doxorubicin | 98.0 % | [78] | Liposome-cellulose | Quercetin | 40.0% | [77] | Liposome-cellulose | Rutin | 58.0% | [77] | Liposome-gel | Lidocaine | 21.6% | [118] | Liposome-gel | Bupivacaine | 98.8% | [119] | Liposome-alginate | Benzocaine | 63.2% | [120] | Liposome-PEG | Lidocaine | 98.8% | [73] | Cyclodextrin/liposome | Quercetin | 91.0% | [121] | Cyclodextrin/liposome | Tretinoin | 88.7% | [122] | Cyclodextrin/liposome | Curcumin | 50.0% | [123] | Cyclodextrin/PLGA | Oxaprozin | 62.0% | [124] | SLN-PLGA-PEG-PLGA | 2-Methoxyestradiol | 91.3% | [125] | SLN-hydrogel | Natural resin | — | [93] | SLN-polycarbophil | Curcumin | 88.1% | [86] | SLN-B12 vitamin | Insulin | 55.9% | [85] | SLN-chitosan | Amphotericin B | 88.5% | [126] | SLN-PLGA | Flurbiprofen | 91.7% | [127] | SLN-dicetyl phosphate | Retinyl palmitate | 99.1% | [128] | SLN-PEG | EGFP Plasmid | 89.0% | [129] | SLN-PEG | Paclitaxel | 11.0% | [130] | SLN-PEG | Salbutamol sulphate | 30.0% | [131] | SLN-PEG | Noscapine | 83.6% | [84] | SLN-chitosan | Carbamazepine | 66.7% | [132] | SLN-chitosan | Ifosfamide | — | [89] | SLN-dextran | Ibuprofen | 99.1% | [133] | SLN-chitosan | Tretinoin | 99.6% | [134] | SLN-PLGA | DNA | 93.1% | [135] | NLC-natural gum (D. regia) | Ondansetron | 29.9% | [95] | NLC-PEG | Fluticasone propionate | 97.0% | [94] | NLC-peptides | Docetaxel | 77.5% | [136] | NLC-PEG | Biochanin A | 99.0% | [137] | NLC-chitosan | Curcumin | 96.6% | [138] | NLC-chitosan | Fubiprofen | 97.5% | [139] | Lipospheres-β-CD | Butyl methoxydibenzoylmethane | 85.0% | [106] | Lipospheres-β-CD | Rifampicin | — | [140] | Lipospheres-PLGA | Albumin | 90.8% | [107] | Lipospheres-PLGA Lipospheres-PEG | Donepezil hydrochloride Ceftriaxone | — 60.1% | [141] [142] | Lipospheres-PEG | Gentamicin | 85.0% | [143] | Lipid nanocapsules | Interleukin-15 (IL-15) | — | [109] | Lipid nanocapsules | Erlotinib | 90.0% | [110] | Lipid nanocapsules | Doxorubicin | 90.0% | [111] | Lipid nanocapsules | Quercetin | 92.0% | [112] |
|
|